IMPORTANT: We are experiencing some technical issues and cannot accept credit card payments at this time. We sincerely apologize for the inconvenience. Please check back later to complete your purchase.
IMPORTANT: We are experiencing some technical issues and cannot accept credit card payments at this time. We sincerely apologize for the inconvenience. Please check back later to complete your purchase.
$249.00
$249– Non-Member
$149 – Member
*Guaranteed lower price for all professions!
*One time use. Not valid with any additional promotional offers.
Legal and regulatory pressure on pharmacists keeps growing, and the cost of a misstep can be steep. Regulatory and Risk Management Essentials for Community Pharmacy Leadership gives you the case-based grounding to handle that pressure with confidence, from the counter to the compliance desk. It’s built for pharmacists who want to lead, not just react.
Pharmacy practice is shaped by an increasingly complex regulatory landscape, making a thorough understanding of pharmacy law and risk management essential for today’s community pharmacy leaders. MasteryRx: Regulatory and Risk Management Essentials for Community Pharmacy Leadership is an 8-hour continuing education program that equips pharmacists with practical strategies to navigate legal responsibilities, strengthen compliance, and reduce professional liability. Through expert-led instruction and real-world legal case studies, learners gain actionable insights they can immediately apply in daily practice.
This comprehensive course explores critical topics including prescription refusal, malpractice prevention, patient counseling obligations, alert fatigue, compounding regulations, inspection readiness, immunization liability, and managing potentially litigious patient interactions. Each module examines current legal standards and regulatory expectations while emphasizing practical risk management strategies that support patient safety and operational excellence. Designed specifically for community pharmacists and pharmacy leaders, this program helps participants build confidence in making legally sound decisions, fostering a culture of compliance, and protecting both patients and their practice.
This program considers the circumstances in which a pharmacist may or must decline a prescription that has been transmitted to a pharmacy. Appropriate reasons for declining a prescription due to potential patient harm are distinguished from inappropriate reasons for declining a prescription that may result in a patient failing to receive necessary medications. The legal case study method is used to evaluate contentions that a pharmacist either should have declined a prescription that was honored, or that a pharmacist should have honored a prescription that was declined. The appropriate use of legal authority to decline a prescription is discussed. The implications for pharmacy practice of these legal cases are evaluated.
The judges who issue rulings on cases of alleged pharmacist malpractice often write opinions that provide concise guidance for pharmacists on complex practice challenges. One of the most significant challenges that can lead to pharmacy malpractice litigation is “look alike and sound alike” drug names that lead to an order processing error. This program describes the facts and the rationale of three such cases. The key issues considered in the cases are technician training and supervision, the need for patient counseling when dispensing a high alert drug, and the appropriate remedial measures following a fatal dispensing error. The reported opinions from the appellate court in the cases provide direction for pharmacy risk management procedures that can reduce exposure to legal liability for order processing errors.
This program examines the underlying legal rationale for recognition of pharmacy practice liability for failure to warn a patient of known risks to the patient that could arise from use of the prescribed medication. The program uses the legal case study method to evaluate lawsuits in which a pharmacist has accurately processed a patient’s prescription, yet the court has ruled that order processing accuracy is insufficient to meet pharmacist professional responsibilities. Distinctions are drawn between the types of information that pharmacists must provide to patients under the recognized legal standard of care, and the types of information that the legal standard of care does not require pharmacist to provide to patients.
The judges who issue rulings on cases of alleged pharmacist malpractice often write opinions that provide concise guidance for pharmacists on complex practice challenges. One of the most significant challenges that can lead to pharmacy malpractice litigation is “look alike and sound alike” drug names that lead to an order processing error. This program describes the facts and the rationale of three such cases. The key issues considered in the cases are technician training and supervision, the need for patient counseling when dispensing a high alert drug, and the appropriate remedial measures following a fatal dispensing error. The reported opinions from the appellate court in the cases provide direction for pharmacy risk management procedures that can reduce exposure to legal liability for order processing errors.
Extemporaneous compounding has been a pharmacist role for many centuries. Many patients require unique medications that meet their specific needs, yet pre-manufactured medications are not available. This program reviews the practice of traditional pharmacy compounding and the liabilities that may arise when compounding errors occur. The program also reviews the unfortunate breakdown in pharmacy practice and pharmacy regulation that has led to the adoption of new requirements that must be met in the extemporaneous preparation of compounded medications for patients. The program reviews the federal laws for compounding pharmacies and compounding outsourcing facilities, within the framework of traditional state regulation of the practice of pharmacy. Practices and procedures for the reduction of legal liability for patient harm that has allegedly been caused by compounded pharmaceuticals are noted.
Pharmacies are subject to inspection by government agencies such as the state board of pharmacy and the federal Drug Enforcement Administration. This program considers the circumstances that can create the appearance of noncompliance when an inspector visits a pharmacy practice site, and the program suggests strategies that can be used to avoid the appearance of noncompliance during an inspection. Quality improvement policies and procedures are discussed as a means to consistently promote regulatory compliance and avoid regulatory violations that could be discovered by an inspector or surveyor who visits a pharmacy practice site.
This program examines the potential liability issues that are associated with the administration of immunizations by pharmacy team members. Legal controversies that arise from refusals by pharmacy team members to administer immunizations are also reviewed. The liability exposure of pharmacies for harm caused by vaccines and by vaccine administration is discussed. The importance of strict adherence to pharmacy protocols for vaccine administration is stressed. The program explains the potential adverse legal consequences for pharmacy personnel who violate pharmacy protocols in the administration of vaccines. Government compensation programs for vaccine-related injuries are explained, and they are distinguished from liability for injuries caused by the inappropriate administration of a vaccine. The legal case study method is used to evaluate how legal standards are applied in litigation that is related to pharmacy immunization practice.
Within any pharmacy practice site interpersonal misunderstandings and disagreements with patients can lead to disappointment and even anger over the slightest error or perceived rudeness. Risk management is an activity that intends to reduce liability exposure, even if errors cannot be prevented. This program investigates the risk management responsibility of every pharmacy practice team member. Although it may not be possible to avoid all errors, it may be possible to avoid malpractice liability for an error if the situation is appropriately managed and if the patient is treated respectfully. This program considers how “difficult” patients can become “litigious” patients simply because they believe they were treated disrespectfully by pharmacy team members and their goal is to call attention to the situation through a preventable lawsuit. Strategies for the avoidance of litigation by the potentially litigious patient are considered.
Great! We work with organizations, large and small, to create discounted CE packages that save you time and money. Ask about our Organization Portal, used by organizations from independent pharmacies to national chains to add, manage, and track team-member CE.
Click the button below to learn more.
$249.00
$249.00
If you already have a freeCE account, click “Account Login” in the navigation bar.
Sign up to PharmCon’s newsletter
to get exclusive discounts on
courses, study tools, and more!
